Naslov
RATIONAL DRUG USE IN A PATIENT WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASES - A CASE STUDY

Autori
Mucalo, Iva ; Bićanić, Lucija Ana ; Brajković, Andrea

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Pharmaca / - Zagreb, 2022, 103-103

Skup
10. hrvatski kongres farmakologije ; 1. hrvatski kongres kliničke farmakologije s međunarodnim sudjelovanjem = 10th Croatian Congress of Pharmacology ; 1st Croatian Congress of Clinical Pharmacology and Therapeutics with International Participation

Mjesto i datum
Opatija, Hrvatska, 22.09.2022. - 25.09.2022

Vrsta sudjelovanja
Pozvano predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Type 2 diabetes ; medication management ; case-study

Sažetak
Introduction Type 2 diabetes (T2DM) is a complex metabolic disorder characterized by elevated blood glucose levels and a marked increase in the risk of cardiovascular disease (CVD). Additionally, CVDs are the number one cause of global mortality, responsible for an estimated 17.9 million deaths each year. Hence, to reduce the risk of cardiovascular complications in patients with T2DM, comprehensive medication management (CMM) is deemed crucial. The purpose of this case-study is to present the process of pharmaceutical care and clinical outcomes in a patient with T2DM and CVD who received CMM services. Methods In CMM services, the fundamental purpose of pharmacist’s work is to address all of a patient’s medication-related needs, optimise their medication use, and improve their health outcomes. The provision of CMM involves a logical and patientcentered approach to medication optimization that ensures every medication used by a patient is appropriate, effective, safe and convenient to be taken. A patient with T2DM and CVD who has undergone an extensive CMM over a 2 year period at the Health care Centre Zagreb is hereby described. Results Patient who participated in more than eleven follow-up visits had her clinical outcomes (blood pressure, HbA1c, LDL and weight) significantly improved through CMM provision. Conclusion As previously shown by an extensive body of evidence, CMM services have demonstrated the positive impact of pharmacists’ interventions on the management of chronic diseases by improving individual cardiovascular risk factors such as blood pressure, glycated haemoglobin and lipid profile.

Izvorni jezik
Engleski

Znanstvena područja
Farmacija

POVEZANOST RADA